David J. DeGraff, Ph.D.
Affiliations: | 2008 | Department of Biological Sciences | University of Delaware, Newark, DE, United States |
Area:
Physiology Biology, Cell Biology, Molecular BiologyGoogle:
"David DeGraff"Parents
Sign in to add mentorRobert A. Sikes | grad student | 2008 | University of Delaware | |
(Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Shuman L, Pham J, Wildermuth T, et al. (2023) Urothelium-specific expression of mutationally activated Pik3ca initiates early lesions of non-invasive bladder cancer. The American Journal of Pathology |
Warrick JI, Hu W, Yamashita H, et al. (2022) FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. Nature Communications. 13: 6575 |
Walter V, DeGraff DJ, Yamashita H. (2022) Characterization of laminin-332 gene expression in molecular subtypes of human bladder cancer. American Journal of Clinical and Experimental Urology. 10: 311-319 |
Torab P, Yan Y, Ahmed M, et al. (2021) Intratumoral Heterogeneity Promotes Collective Cancer Invasion through NOTCH1 Variation. Cells. 10 |
Iyyanki T, Zhang B, Wang Q, et al. (2021) Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer. Genome Biology. 22: 105 |
Connelly ZM, Jin R, Zhang J, et al. (2020) FOXA2 promotes prostate cancer growth in the bone. American Journal of Translational Research. 12: 5619-5629 |
Torab P, Yan Y, Yamashita H, et al. (2020) Three-Dimensional Microtumors for Probing Heterogeneity of Invasive Bladder Cancer. Analytical Chemistry |
Meeks JJ, Al-Ahmadie H, Faltas BM, et al. (2020) Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nature Reviews. Urology |
Russo M, Newell JM, Budurlean L, et al. (2020) Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma. Cancer |
Li H, Zhang Q, Shuman L, et al. (2020) Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes. Scientific Reports. 10: 1439 |